Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver transplant study tests best way to manage fluids during surgery

NCT ID NCT05647733

First seen Feb 25, 2026 · Last updated Jun 22, 2026 · Updated 15 times

Summary

This pilot study compares two approaches to giving fluids during liver transplant surgery: a restrictive strategy that removes some blood early and returns it later, versus a liberal strategy that keeps blood flow high. The goal is to see if a larger study is possible by checking recruitment rates and how well doctors follow the plan. About 138 adults with end-stage liver disease will take part across four Canadian hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Hospitalier de l'Université de Montréal (CHUM)

    Montreal, Quebec, H2X 0C1, Canada

  • London Health Sciences Centre

    London, Ontario, N6G 2V4, Canada

  • McGill University Health Centre

    Montreal, Quebec, H4A 3J1, Canada

  • Vancouver General Hospital

    Vancouver, British Columbia, V5Z 1M9, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could show which fluid management method is safer for liver transplant patients and pave the way for a larger, definitive trial.

What could go wrong

This is a small pilot study focused on feasibility, not on proving which strategy is better. Results may not apply to all patients or hospitals.

Conditions

The condition(s) this trial relates to.

chronic liver failure End Stage Liver Disease Liver Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.